Chinese- and French-Manufactured Immediate-Release Glucophage ® Bioequivalence: A Randomized, Open-Label, Crossover Study.

Bibliographic Details
Title: Chinese- and French-Manufactured Immediate-Release Glucophage ® Bioequivalence: A Randomized, Open-Label, Crossover Study.
Authors: Hu C; Department of Pharmacy, Phase I Clinical Trial Center, Xuanwu Hospital of Capital Medical University, National Clinical Research Center for Geriatric Diseases, No. 45 Changchun Street, Xicheng District, Beijing, China., Gao D; Department of Pharmacy, Phase I Clinical Trial Center, Xuanwu Hospital of Capital Medical University, National Clinical Research Center for Geriatric Diseases, No. 45 Changchun Street, Xicheng District, Beijing, China., Li D; Merck Serono (Beijing) Pharmaceutical R&D Co., Ltd (an affiliate of Merck KGaA), Beijing, China., Zhou D; Merck Serono (Beijing) Pharmaceutical R&D Co., Ltd (an affiliate of Merck KGaA), Beijing, China., Zhang L; Department of Pharmacy, Phase I Clinical Trial Center, Xuanwu Hospital of Capital Medical University, National Clinical Research Center for Geriatric Diseases, No. 45 Changchun Street, Xicheng District, Beijing, China. xwzhanglan@126.com.
Source: Drugs in R&D [Drugs R D] 2022 Dec; Vol. 22 (4), pp. 301-309. Date of Electronic Publication: 2022 Oct 20.
Publication Type: Randomized Controlled Trial; Journal Article
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100883647 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-6901 (Electronic) Linking ISSN: 11745886 NLM ISO Abbreviation: Drugs R D Subsets: MEDLINE
Database: MEDLINE Complete
Full text is not displayed to guests.
Description
ISSN:1179-6901
DOI:10.1007/s40268-022-00405-3